| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2500220 | Farmacia Hospitalaria | 2010 | 9 Pages |
Abstract
The greatest cost and percentage of adherent patients associated with the combos composed of Tenovovir/Emtricitabine(TDF/FTC) and ABC/3TC, and the least cost and effectiveness of those composed of AZT/#TC and ABC/AZT/3TC, does not allow us to identify any option as significantly dominant. The regimens with ABC/3TC were shown to be the most favourable from the combined point of view of cost and adherence.
Keywords
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmaceutical Science
Authors
J.M. Ventura-Cerdá, D. Ayago-Flores, E. Vicente-Escrig, S. Mollá-Cantavella, M. Alós-Almiñana,